Insiders · Profile

SKOLNICK MARK H

Chief Scientific Officer at MYRIAD GENETICS. Filing since 12 Mar 2007. CIK 0001008315

Company
Date
Role
Action
Shares
Amount
Of holding
5 Nov 2009
Chief Scientific Officer
Sold, plan not stated
65,000
$1.61M
11.2%
5 Nov 2009
Chief Scientific Officer
Sold, plan not stated
16,000
$395.32K
32.0%
4 Nov 2009
Chief Scientific Officer
Sold, plan not stated
80,000
$2.08M
12.6%
4 Nov 2009
Chief Scientific Officer
Sold, plan not stated
16,000
$415.68K
24.2%
4 Nov 2009
Chief Scientific Officer
Sold, plan not stated
15,000
$389.70K
11.8%
11 May 2009
Chief Scientific Officer
Sold, plan not stated
6,992
$227.24K
1.2%
8 May 2009
Chief Scientific Officer
Sold, plan not stated
4,601
$149.95K
0.8%
7 May 2009
Chief Scientific Officer
Sold, plan not stated
10,399
$334.47K
1.8%
4 Mar 2009
Chief Scientific Officer
Sold, plan not stated
2,000
$158.00K
0.7%
27 Feb 2009
Chief Scientific Officer
Sold, plan not stated
9,000
$723.24K
3.2%
10 Nov 2008
Chief Scientific Officer
Sold, plan not stated
10,000
$711.50K
3.7%
16 Sep 2008
Chief Scientific Officer
Sold, plan not stated
14,500
$957.00K
5.4%
16 Sep 2008
Chief Scientific Officer
Sold, plan not stated
5,000
$330.00K
13.2%
3 Sep 2008
Chief Scientific Officer
Sold, plan not stated
500
$34.26K
0.2%
20 Mar 2008
Chief Scientific Officer
Sold, plan not stated
20,000
$700.85K
7.3%
7 Feb 2008
Chief Scientific Officer
Sold, plan not stated
25,000
$975.08K
8.7%
6 Dec 2007
Chief Scientific Officer
Sold, plan not stated
20,000
$1.01M
6.0%
6 Dec 2007
Chief Scientific Officer
Sold, plan not stated
7,000
$353.28K
6.6%
31 May 2007
Chief Scientific Officer
Sold, plan not stated
30,000
$1.15M
8.8%
8 May 2007
Chief Scientific Officer
Sold, plan not stated
30,000
$1.14M
8.8%
12 Mar 2007
Chief Scientific Officer
Sold, plan not stated
5,000
$169.05K
1.6%
21 decisions on file.